Product Information |
|
Registration Number |
DR-XY 47704
|
Generic Name |
Ibrutinib
|
Brand Name |
Imbruvica
|
Dosage Strength |
140 mg
|
Dosage Form |
Capsule
|
Classification |
Prescription Drug (RX)
|
Packaging |
White opaque HDPE bottle with white opaque child -
resistant PP closure and foil induction seal containing 90 capsules (Box of l's) White opaque HDPE bottle with white opaque child - resistant PP closure and foil induction seal containing 120 capsules (Box of l's)
|
Pharmacologic Category |
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Manufacturer |
Cilag AG
|
Country of Origin |
Switzerland
|
Trader |
N/A
|
Importer |
Johnson & Johnson (Philippines), Inc.
|
Distributor |
N/A
|
Application Type |
Monitored Release
|
Issuance Date |
04 February 2022
|
Expiry Date |
04 February 2027
|